(Q24246666)

26 November 2023

Isabel Huertas

2

I

Huertas

1 reference

26 November 2023

Inmaculado Pereiro

3

I I

Pereiró

1 reference

26 November 2023

José Sanfélix

4

J

Sanfélix

1 reference

26 November 2023

Victoria Gosalbes

5

V

Gosalbes

1 reference

26 November 2023

Carla Perrotta

6

C

Perrota

1 reference

Cochrane Database of Systematic Reviews

26 November 2023

publication date

19 July 2004

0 references

published in

0 references

cites work

A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

The use of small doses of cephalexin (125 mg) in the management of recurrent urinary tract infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

A Controlled Study of Antimicrobial Prophylaxis of Recurrent Urinary Infection in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Prophylaxis of recurrent urinary tract infection in female patients. Efficacy of low-dose, thrice-weekly therapy with trimethoprim-sulfamethoxazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Secondary prevention of recurrent urinary tract infections. Comparison of the effect of placebo, methenamine hippurate, nitrofurantoin and trimethoprim alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Low dose trimethoprim prophylaxis in long term control of chronic recurrent urinary tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Management of recurrent urinary tract infections with patient-administered single-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Confidence intervals for the number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Empirical treatment of uncomplicated cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Urinary tract infection: self-reported incidence and associated costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

A prospective study of risk factors for symptomatic urinary tract infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Cranberries for preventing urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Trimethoprim alone in the treatment and prophylaxis of urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001209.PUB2

Prevention of recurrent urinary tract infections in postmenopausal women

21 January 2018

1 reference

12 December 2020

Prevention of recurrent urinary tract infection in adults

1 reference

12 December 2020

Long-term single dose chemoprophylaxis of recurrent urinary tract infection in elderly female subjects

1 reference

12 December 2020

Patient compliance and efficacy of low-dose, long-term prophylaxis in patients with recurrent urinary tract infection

1 reference

12 December 2020

[Prevention of recurrent cystitis in fertile women. A double-blind comparison of Hiprex and placebo in general practice]

1 reference

12 December 2020

Comparison of long-term, low-dosage nitrofurantoin, methenamine hippurate, trimethoprim and trimethoprim-sulphamethoxazole on the control of recurrent urinary tract infection

1 reference

12 December 2020

Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women

1 reference

12 December 2020

Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection

1 reference

12 December 2020

Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women

1 reference

12 December 2020

[Frequent cystitis in elderly women. A double-blind comparison of Hiprex and placebo in general practice]

1 reference

12 December 2020

Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women.

1 reference

12 December 2020

[A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study)]

1 reference

12 December 2020

Controlled trial comparing co-trimoxazole and methenamine hippurate in the prevention of recurrent urinary tract infections

1 reference

12 December 2020

Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion.

1 reference

12 December 2020

Risk Factors for Recurrent Urinary Tract Infection in Young Women

1 reference

12 December 2020

Recurrent urinary tract infections in postmenopausal women

1 reference

12 December 2020

[Clinical studies of antimicrobial prophylaxis of recurrent urinary infection in women. Long-term, low-dose pipemidic acid for prophylaxis]

1 reference

12 December 2020

Prophylactic long-term cephalexin in recurrent urinary infection.

1 reference

12 December 2020

Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Recurrent urinary tract infections in premenopausal women: prophylaxis based on an understanding of the pathogenesis

1 reference

12 December 2020

[Preventive treatment of recurrent cystitis in women. Double-blind randomized study using cinoxacin and placebo]

1 reference

12 December 2020

Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections

1 reference

12 December 2020

Cranberries for preventing urinary tract infections

1 reference

12 December 2020

Secondary prevention of urinary tract infections. The role of trimethoprim alone

1 reference

12 December 2020

Urinary prophylaxis with trimethoprim and trimethoprim-sulfamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control.

1 reference

12 December 2020

Does antibacterial ointment applied to urethral meatus in women prevent recurrent cystitis?

1 reference

12 December 2020

Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomized study

1 reference

12 December 2020

Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Low-dose norfloxacin versus placebo for long-term prophylaxis of recurrent uncomplicated urinary tract infection

1 reference

12 December 2020

Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate

1 reference

12 December 2020

Recurrent Urinary Tract Infections in Women: Prevention by Topical Application of Antimicrobial Ointment to Urethral Meatus

1 reference

12 December 2020

Comparison of low-dose cinoxacin therapy and placebo in the prevention of recurrent urinary tract infections

1 reference

12 December 2020

Prevention of subsequent urinary tract infections in women by the use of anti-adherence antimicrobial agents: a double-blind comparison of enoxacin with co-trimoxazole

1 reference

12 December 2020

Prevention of urinary-tract infection with low-dose nitrofurantoin

1 reference

12 December 2020

Prophylactic efficacy of cinoxacin in recurrent urinary tract infection: biologic effects on the vaginal and fecal flora

1 reference

12 December 2020

Prevention of recurrent urinary tract infections in premenopausal women by post-coital administration of cinoxacin

1 reference

12 December 2020

Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin.

1 reference

12 December 2020

Cefaclor as a prophylactic agent for recurrent urinary infections: a comparative trial with macrocrystalline nitrofurantoin

1 reference

12 December 2020

Pivmecillinam in long-term prophylaxis to girls with recurrent urinary tract infection

1 reference

12 December 2020

Long-term low dose cinoxacin therapy for the prevention of recurrent urinary tract infections

1 reference

12 December 2020

[Prevention of recurrent urinary tract infection with cinoxacin. A comparative study with nitrofurantoin]

1 reference

12 December 2020

Recurrent urinary infections in women: clinical trial of cephradine as a prophylactic agent

1 reference

12 December 2020

[Antibioprevention of recurrent cystitis. A randomized double-blind comparative trial of 2 dosages of pefloxacin]

1 reference

12 December 2020

Long-Term Prophylaxis of Urinary Infections in Women: Comparative Trial of Trimethoprim, Methenamine Hippurate and Topical Povidone-Iodine

1 reference

12 December 2020

Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020